[go: up one dir, main page]

CY1107672T1 - Φαρμακευτικες και/ή κοσμητικες συνθεσεις για τη θεραπεια εντοπισμενου αδιπικου ιστου και κυτταριτιδας - Google Patents

Φαρμακευτικες και/ή κοσμητικες συνθεσεις για τη θεραπεια εντοπισμενου αδιπικου ιστου και κυτταριτιδας

Info

Publication number
CY1107672T1
CY1107672T1 CY20071100788T CY071100788T CY1107672T1 CY 1107672 T1 CY1107672 T1 CY 1107672T1 CY 20071100788 T CY20071100788 T CY 20071100788T CY 071100788 T CY071100788 T CY 071100788T CY 1107672 T1 CY1107672 T1 CY 1107672T1
Authority
CY
Cyprus
Prior art keywords
pharmaceutical
cosmetic compositions
ottoman
cellular
tissue
Prior art date
Application number
CY20071100788T
Other languages
English (en)
Inventor
Pierro Francesco Di
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Publication of CY1107672T1 publication Critical patent/CY1107672T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Η παρούσα εφεύρεση έχει σχέση με φαρμακευτικές και/ή κοσμητικές συνθέσεις που περιέχουν ένα συνδυασμό των παρακάτω δραστικών συστατικών α) σύμπλοκο εσκινο/βήτα-σιστερόλης με φωσφολιπίδια, β) σύμπλοκο διμερών φλαβονοϊδων Ginkgo biloba με φωσφολιπίδια, γ) σύμπλοκο τριτερπενίων Centella asiatica με φωσφολιπίδια, και προαιρετικά ένα ή και τα δύο από: δ) αιθυλο-ξιμενινικό, ε)πρότυπο εκχύλισμα Coleus forskolii.
CY20071100788T 2001-06-05 2007-06-14 Φαρμακευτικες και/ή κοσμητικες συνθεσεις για τη θεραπεια εντοπισμενου αδιπικου ιστου και κυτταριτιδας CY1107672T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI001182A ITMI20011182A1 (it) 2001-06-05 2001-06-05 Composizioni farmaceutiche e/o cosmetiche per il trattamento di adiposita' localizzate e della cellulite
EP02732718A EP1392335B1 (en) 2001-06-05 2002-05-16 Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite

Publications (1)

Publication Number Publication Date
CY1107672T1 true CY1107672T1 (el) 2013-04-18

Family

ID=11447807

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100788T CY1107672T1 (el) 2001-06-05 2007-06-14 Φαρμακευτικες και/ή κοσμητικες συνθεσεις για τη θεραπεια εντοπισμενου αδιπικου ιστου και κυτταριτιδας

Country Status (23)

Country Link
US (1) US7476392B2 (el)
EP (1) EP1392335B1 (el)
JP (1) JP4762492B2 (el)
KR (1) KR100869868B1 (el)
CN (1) CN100340247C (el)
AT (1) ATE360427T1 (el)
AU (1) AU2002304632B2 (el)
CA (1) CA2449485C (el)
CY (1) CY1107672T1 (el)
CZ (1) CZ300576B6 (el)
DE (1) DE60219782T2 (el)
DK (1) DK1392335T3 (el)
ES (1) ES2284870T3 (el)
HK (1) HK1063295A1 (el)
HU (1) HU230348B1 (el)
IT (1) ITMI20011182A1 (el)
NO (1) NO331789B1 (el)
PL (1) PL204550B1 (el)
PT (1) PT1392335E (el)
RU (1) RU2291683C2 (el)
SI (1) SI1392335T1 (el)
SK (1) SK287612B6 (el)
WO (1) WO2002098436A1 (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20021280A1 (it) * 2002-06-11 2003-12-11 Carlo Ghisalberti Metodo di trattamento anticellulite
FR2841470B1 (fr) * 2002-06-27 2006-01-13 Pharmascience Lab Utilisation d'isoflavones pour la preparation de compositions topiques utiles pour favoriser l'amincissement et methode de traitement cosmetique associee
ITMI20031427A1 (it) * 2003-07-11 2005-01-12 Indena Spa Combinazioni di agenti vasoattivi, loro uso in campo farmaceutico e cosmetico e formulazioni che li contengono
ITMI20031428A1 (it) * 2003-07-11 2005-01-12 Indena Spa Combinazioni di agenti vasoattivi e loro uso per il trattamento di disfunzioni sessuali
US20050089555A1 (en) * 2003-10-24 2005-04-28 Aventis Pharma Deutschland Gmbh Medicinal targeted local lipolysis
DE10349979B4 (de) * 2003-10-24 2006-05-18 Sanofi-Aventis Deutschland Gmbh Medikamentöse gezielte lokale Lipolyse
US20050143347A1 (en) * 2003-12-22 2005-06-30 Aventis Pharma Deutschland Gmbh Medicinal lipolysis of accumulations of fat
BRPI0518554A2 (pt) * 2004-12-14 2008-11-25 Menarini Ricerche Spa uso de um inibidor de pde3
WO2006073190A1 (ja) * 2005-01-07 2006-07-13 Rohto Pharmaceutical Co., Ltd. 外用組成物
DE102005061071A1 (de) * 2005-12-21 2007-06-28 Kneipp-Werke Kneipp-Mittel-Zentrale Gmbh & Co. Kg Wirkstoffkombination aus Santalbinsäure oder Derivate davon und Traubenkernöl zur topischen oder dermatologischen Verwendung
DE102007007610A1 (de) * 2007-02-13 2008-08-14 Beiersdorf Ag Verfahren zur Steigerung der Hautelastizität und/oder eine Stärkung der Spannkraft der Haut
ITTO20070391A1 (it) * 2007-06-05 2008-12-06 Medestea Res & Production S P Composizione di integratore alimentare,farmaco o dispositivo medicale e suo impiego per sopprimere l'appetito, migliorare tono ed umore, con attivita antidepressiva naturale e con effetto antiastenico
EP2419437A1 (en) * 2009-04-17 2012-02-22 Lipotec, S.A. Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions
EP2464348B1 (en) * 2009-08-12 2013-06-19 Horphag Research IP (Pyc) Ltd. Combination of proantocycidins such as pycnogenol or grape seeds and centella asiatica for the treatment of cardiovascular diosorders such as atherosclerosis
DE102009028996A1 (de) * 2009-08-28 2011-03-03 Rovi Cosmetics International Gmbh Kosmetische Formulierung zur Reduktion der äußeren Erscheinungsbilder von Cellulite oder Orangenhaut
FR2962907B1 (fr) * 2010-07-21 2015-05-08 Ephyla Sas Extrait de vegetal pour la fabrication de composition amincissante et procede de controle pour mincir mettant en oeuvre une telle composition
BE1022293B1 (nl) 2012-11-21 2016-03-14 Wendy Angrave Methode en composities om toxines te verwijderen uit het lichaam
CA2905756C (en) * 2013-03-15 2016-11-29 Mary Kay Inc. Cosmetic compositions for reducing the appearance of cellulite or improving skin texture
CN103432045B (zh) * 2013-09-06 2015-06-24 雅露拜尔生物科技（杭州）有限公司 健美瘦身组合物及健美瘦身霜
US20240148686A1 (en) * 2021-02-24 2024-05-09 China Pharmaceutical University Pharmaceutical composition of forskolin-isoforskolin and pentacyclic triterpenoid compound, and application thereof
EP4487835A1 (en) * 2023-07-07 2025-01-08 Shiseido Co., Ltd. Use of whole plants in cosmetic compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1203515B (it) * 1987-02-26 1989-02-15 Indena Spa Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
IT1223290B (it) * 1987-07-27 1990-09-19 Indena Spa Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche
FR2669537B1 (fr) * 1990-11-28 1993-02-19 Oreal Composition amincissante a base d'alpha-2-bloqueurs.
FR2684300B1 (fr) * 1991-11-29 1994-03-11 Lvmh Recherche Composition cosmetique ou pharmaceutique, notamment dermatologique, destinee en particulier a favoriser la pigmentation de la peau ou des cheveux, contenant un extrait de ballote, et son procede de fabrication.
JPH10182473A (ja) * 1996-12-25 1998-07-07 Lion Corp 皮下脂肪代謝促進剤及びそれを含む外用組成物
ATE292469T1 (de) * 1999-09-10 2005-04-15 Ceteris Holding B V Amsterdam Ein antioxyrierungsmittel auf basis von pflanzenextrakten zur behandlung von kreislaufs- und fettsuchtproblemen

Also Published As

Publication number Publication date
SK287612B6 (sk) 2011-04-05
AU2002304632B2 (en) 2006-07-20
HU230348B1 (hu) 2016-02-29
CA2449485A1 (en) 2002-12-12
DE60219782T2 (de) 2008-01-24
RU2291683C2 (ru) 2007-01-20
PT1392335E (pt) 2007-07-17
CZ20033293A3 (en) 2004-04-14
JP4762492B2 (ja) 2011-08-31
KR100869868B1 (ko) 2008-11-24
CN100340247C (zh) 2007-10-03
NO20035389D0 (no) 2003-12-04
ITMI20011182A0 (it) 2001-06-05
HK1063295A1 (en) 2004-12-24
CN1512889A (zh) 2004-07-14
CA2449485C (en) 2010-09-28
HUP0400119A3 (en) 2007-10-29
EP1392335B1 (en) 2007-04-25
SK14852003A3 (sk) 2004-05-04
NO331789B1 (no) 2012-04-02
PL204550B1 (pl) 2010-01-29
DE60219782D1 (de) 2007-06-06
US7476392B2 (en) 2009-01-13
PL366914A1 (en) 2005-02-07
SI1392335T1 (sl) 2007-08-31
KR20040030637A (ko) 2004-04-09
WO2002098436A1 (en) 2002-12-12
JP2004532273A (ja) 2004-10-21
DK1392335T3 (da) 2007-09-17
EP1392335A1 (en) 2004-03-03
ITMI20011182A1 (it) 2002-12-05
ATE360427T1 (de) 2007-05-15
CZ300576B6 (cs) 2009-06-17
US20040151786A1 (en) 2004-08-05
RU2003135427A (ru) 2005-03-20
ES2284870T3 (es) 2007-11-16
HUP0400119A2 (hu) 2005-09-28

Similar Documents

Publication Publication Date Title
CY1107672T1 (el) Φαρμακευτικες και/ή κοσμητικες συνθεσεις για τη θεραπεια εντοπισμενου αδιπικου ιστου και κυτταριτιδας
TR200500745T2 (tr) Damar gelişimi inhibitörleri olarak kuinazolin türevleri.
BR0207930A (pt) Composições farmacêuticas lìquidas com sabor mascarado
IT1288290B1 (it) Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie
BRPI0409516A (pt) composição, uso de uma composição e processo de melhora da penetração de um ativo farmacêutico
BR0212921A (pt) Composição farmacêutica com base em fondant
BRPI0009299B8 (pt) formas de administração farmacêuticas mecanicamente estáveis para administração por via oral, e, processo para produzir formas de administração farmacêuticas mecanicamente estáveis.
DE60019334D1 (de) Antivirale arznei
BR0014312B1 (pt) composição farmacêutica contendo uma combinação farmacêutica compreendendo loteprednol e azelastina, medicamento e seu processo de produção, e uso da referida combinação.
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
PL366605A1 (en) Pharmaceutical and cosmetic compositions against skin aging
MXPA05013270A (es) Forma de administracion transmucosal con irritacion mucosal reducida. reducida.
BR0013106A (pt) Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido.
DE50211212D1 (de) Pharmazeutische zubereitung enthaltend wirkstoffe aus den pflanzen centella asiatica, mahonia aquifolium und viola tricolor
CY1107227T1 (el) Θεραπεια αυτοανοσων νοσων με εκχυλισμα αμερικανικου γκινσενγκ
CY1106561T1 (el) Συνθεσεις χορηγουμενες απο το στομα για την θεραπεια της κυτταριτιδας
BR0202759A (pt) Composição farmacêutica de liberação modificada contendo bupropiona como substância ativa
EP1055415A3 (de) Wirkstoffkombinationen aus Bornitrid und Flavonderivaten und/oder Flavanonderivaten, insbesondere von Flavonoiden, sowie kosmetische Zubereitungen, solche Wirkstoffkombinationen enthaltend
ECSP044944A (es) Derivados sustituidos de 4-aminociclohexanol
FI20011192A0 (fi) Flavonoidilääkeaine ja annostusmuoto, sen valmistus ja käyttö
UA34406A (uk) Засіб для лікування розсіяного склерозу, спосіб лікування з його використанням та фармацевтична упаковка
UY24489A1 (es) Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimiento para su preparación y aplicación de estos compuestos en medicamentos.
BR0207299A (pt) Composição farmacêutica, solução aquosa e métodos para fabricar e para preparar uma composição, para instruir um humano a ingerir uma composição farmacêutica de liberação imediata e para tratar um humano
UA41161A (uk) Склад для лікування пародонтиту